Pharmaceutical News and Articles

Difficult Menopause Could Be Warning Sign For Future Dementia

Hot flashes, night sweats and other symptoms of a difficult menopause could be early warning flags for dementia, a new study suggests. Women who exhibit more me

GLP-1 Drugs Improve Outlook For Kidney Transplants

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients type 2 di

Cancer Screening Rates Rebound Post-Pandemic

Preventive screenings for cancer declined during the pandemic, with lockdowns, social distancing and COVID-19 surges keeping many from needed mammograms and col

Breastfeeding Improves Heart Health In Children

Breastfeeding can promote lower blood pressure among children, a new study says. Longer-term breastfeeding appears to populate a baby s gut with diverse bacteri

NIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain. The drug, kn

ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic Reactions in Pediatric Patients

FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children

The U.S. Food and Drug Administration has expanded its indication of Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced al

Complications, Mortality Up With Surgery Immediately Preceding Weekend

Patients who undergo surgery immediately preceding the weekend have an increased risk for complications, readmission, and mortality at 30 days, 90 days, and one

Long-Term NSAID Use Linked to Reduced Dementia Risk

Long-term nonsteroidal anti-inflammatory drug (NSAID) use is associated with reduced dementia risk, according to a study published online March 5 in the Journal

Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF

Tenax Therapeutics, Inc. (Nasdaq TENX) ( Tenax Therapeutics or the Company ), a Phase 3, development-stage pharmaceutical company using clinical insights to dev